Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.521 | Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial | Dr. LAI Jimmy Che To |
| 2019.524 | Bayer 20810 - A Phase 1/2 Study of the TRK Inhibitor Selitrectinib (BAY 2731954) in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers Formerly: LOXO-EXT-17005 - A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers | Dr. LOONG Herbert Ho Fung |
| 2022.504 | Bayesian dosing calculator of intravenous vancomycin in critically ill neonates: model evaluation and clinical significance study |
Dr. LAM Tai Ning 林泰寧 |
| 2023.150 | Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of zongertinib (BI 1810631) as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2024.397 | Beamion LUNG-2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered zongertinib (BI 1810631) compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations | Dr. LOONG Ho Fung Herbert |
| 2010.137 | BEGIN | Dr. Chow Chun Chung |
| 2009.532 | BEGIN: ONCE ASIA A Pan Asian trial comparing efficacy and safety of insulin NN1250 and insulin glargine as add on to OAD(s) in subjects with type 2 diabetes. A 26-week randomised, confirmatory, controlled, open label, multicentre, multinational treat-to-target trial comparing the efficacy and safety of SIBA and insulin glargine, both injected once daily as add on to current OAD treatment in insulin na・e subjects with type 2 diabetes mellitus qualifying for more intensified treatment | Dr Chow Francis Chun-Chung |
| 2024.115 | Behavior, Aspirations and Treatment needs of people living with hepatitis B | Professor Wong Lai Hung Grace |
| 2013.124 | Behavioral and Neurologic Factors in Speech Learning | Prof. WONG Patrick Chun Man |
| 2023.415 | Behavioral Determinants of Eye Functions and Health in Humans |
Prof. WONG Stephen Heung Sang 王香生 |
| 2007.424 | Behavioral Health Informatics Capacity - Building in China | LAU TF Joseph |
| 2023.426 | Behavioural Disinhibition in Stroke |
Prof. TANG Wai Kwong Wai Kwong Tang |
| 2016.289 | Behavioural Disinhibition in Stroke |
Prof. TANG Wai Kwong 鄧偉光 |
| 2013.616 | Behavioural Dysexecutive Syndrome after Stroke | Prof. TANG Wai Kwong |
| 2005.097 | Behavioural Intervention in the Management of Childhood Asthma | LI Albert Martin |
| 2017.609 | Beneficial effects of high flow nasal cannula (HFNC) versus standard low flow nasal cannula in patients undergoing left atrial appendage occlusion (LAAO) under deep sedation: A randomized pilot crossover trial |
Dr. TSANG Teresa Hing Yan 曾慶恩 |
| 2016.444 | Beneficial efficacy of combined therapy using turmeric and chemotherapeutics in colorectal cancer – a final proof prior to clinical trial |
Prof. LAU Clara Bik San 劉碧珊 |
| 2008.558 | Benefit of Yoga on Low Back Pain | Cheng Kai Fun Derek |
| 2017.537 | Benefits and efficacy of the cochlear implant System in subjects with unilateral or asymmetrical sensorineural severe-to-profound hearing loss |
Prof. TONG Michael Chi Fai 唐志輝 |
| 2019.707 | Benefits of 8 Weeks Light Physical Activity or Moderate-to-vigorous Physical Activity on Cardiometabolic Markers in Sedentary Overweight/Obese Males |
Ms. ZHENG Chen 鄭晨 |
| 2014.660 | Benefits of UltraZoom for Understanding Speech in Noise | Dr. NG Iris Hoi Yee |
| 2014.014 | Benefits, safety and efficacy of the HiResolution™ Bionic Ear cochlear implant System including the HiFocus Mid-Scala electrode array, in subjects with uni- or bilateral acquired sensorineural severe-to-profound hearing loss | Prof. TONG Michael Chi-Fai |
| 2014.385 | Best practice of holistic care: A case study approach | Dr. LUK Andrew Leung |
| 2015.563 | Beta cell function and insulin sensitivity in Chinese with young onset type 2 diabetes and their siblings – a pilot study | Dr. CHOW Elaine Yee Kwan |
| 2016.446 | Bicycle related injuries at a local emergency department in Hong Kong. | Dr. LEUNG Yuen Hung |
| 2004.252 | Binge Eating Disorder and Other Psychopathology in Obese Chinese Out-Patients in Hong Kong | LAU Lai Shan Lisa |
| 2015.572 | Bio-psycho-social pathways underlying the effects of qigong among comorbid depressed elderly with chronic conditions |
Dr. LEUNG Maria Kwan Wa 梁堃華 |
| 2020.126 | BIO|MASTER.Selectra 3D |
Dr. CHAN Chin Pang 陳展鵬 |
| 2014.026 | Biobank - Investigating the Gut Microbiota, Genetics, Epigenetics and Metabolites | Prof. NG Siew Chien |
| 2021.514 | Biobank for Microbiota Research (Biobank-Microbiota) |
Prof. NG Siew Chien 黃秀娟 |
| 2012.219 | Biochemical and Genetic Analysis in a Family with Butyrylcholinesterase Deficiency | Dr CHAN Matthew Tak Vai |
| 2020.290 | Biodegradable Magnesium Screws in Elbow Fracture Fixation: Clinical Case Series |
Prof. WONG Ronald Man Yeung 黃文揚 |
| 2006.314 | Bioequivalence Studies on Hydroxychloroquine (BABE-O06-040) | CHOW Sing Sum Moses |
| 2018.120 | Biofabrication of cartilage and bone like tissue for Otorhinolaryngology-Head and Neck surgery application |
Prof. TONG Michael Chi Fai 唐志輝 |
| 2017.123 | Biofeedback-informed approach to evaluation and optimization of cochlear implant processing strategies for tone languages |
Dr. LEE Tan 李丹 |
| 2020.154 | BIOFLOW-DAPT: BIOTRONIK – A Prospective, Randomized, Multi-center Study to Assess the SaFety of the Orsiro Mission Stent compared to the ResoLute Onyx Stent in Subjects at High Risk for Bleeding in combination With 1-month Dual AntiPlatelet Therapy |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.459 | BioFreedom Ultra Stent in Hong Kong All Comers Registry |
Prof YAN Bryan Ping Yen 甄秉言 |
| 2015.086 | Bioimpedance spectroscopic detection of altered fluid status among elderly sub-acute congestive heart failure patients: an observational cohort study | Dr. OR Kevin Ka Hang |
| 2020.043 | Bioinformatics evaluation of influenza vaccine match and effectiveness |
Prof. WANG Maggie Haitian 王海天 |
| 2003.154 | Biological Activity of Wound Fluid | Dr. Wo Chiu Tor |
| 2006.138 | Biological and Molecular Characterisation of Placental-Expressed mRNA in Maternal Plasma | CHIU WK Rossa |
| 2010.594 | Biological changes in Thyroid associated orbitopathy/Graves’ Ophthalmopathy (TAOB): Hong Kong Thyroid Eye Assessment and Management (HK-TEAM) Study | Dr. CHONG Kelvin Kam Lung |
| 2008.196 | Biological Implication of Elefated Serum Hepatocyte Growth Factor (HGF) in the Progressionof Nasopharyngeal Carcinoma (NPC) | Ph.D., Assistant Professor LUI Wai Yan Vivian |
| 2022.462 | Biological Typing of Sinonasal Diseases |
Dr. YEUNG David 楊駿文 |
| 2022.488 | Biologics therapy in paediatric rheumatic disease in Hong Kong | Dr. CHAN Oi Man |
| 2022.489 | Biologics therapy in paediatric rheumatic disease in Hong Kong |
Dr. CHIANG Pui King 蔣珮琼 |
| 2023.202 | Biomarker and molecular analysis of gynecological neoplasms | Dr. LI Joshua |
| 2008.009 | Biomarkers for Elevated Overall Cancer Risk in Type 2 Diabetes | Dr Yang Xilin |
| 2019.085 | Biomarkers for poor responders to neoadjuvant chemoradiotherapy for locally advanced rectal cancer |
Dr. HO Sandy Sze Ki 何詩琪 |
| 2014.233 | Biomarkers for risk stratification of oligodendrogliomas beyond 1p/19q codeletion | Prof. NG Ho Keung |
Page 66 of 254.